Dedifferentiated Adenoid Cystic Carcinoma: A Clinicopathologic Study of 6 Cases

Modern Pathology

Volumn 16, Issue 12, 2003, Pages 1265-1272

  Nagao, Toshitaka ^a   Gaffey, Thomas A ^a   Serizawa, Hiromi ^b   Sugano, Isamu ^c   Ishida, Yasuo ^c   Yamazaki, Kazuto ^c   Tokashiki, Ryoji ^b   Yoshida, Tomoyuki ^b   Minato, Hiroshi ^a   Kay, Paul A ^a   Lewis, Jean E ^a  

^a MAYO CLINIC   (United States)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Adenoid cyst; Carcinoma; Dedifferentiation, HER 2 neu; p53; Rb; Salivary gland

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAXILLARY SINUS; METASTASIS; NOSE CAVITY; ONCOGENE NEU; POINT MUTATION; PRIORITY JOURNAL; SUBMANDIBULAR GLAND; TUMOR VOLUME;

ADULT; AGED; BASE SEQUENCE; CA-15-3 ANTIGEN; CARCINOMA, ADENOID CYSTIC; CELL DIFFERENTIATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; RECEPTOR, ERBB-2; S100 PROTEINS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0346992282     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000097366.88165.08     Document Type: Article

References (34)

1. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer 1978;42:265-82.
2. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984;54:1062-9.
3. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands: a study of 61 cases with clinicopathologic correlation. Cancer 1986;57: 312-9.
4. Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol 1990;99:1007-9.
5. Dahlin DC, Beabout JW. Dedifferentiation of low-grade chondrosarcomas. Cancer 1971;28:461-6.
6. Stanley RJ, Weiland LH, Olsen KD, Pearson BW. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland. Otolaryngol Head Neck Surg 1988;98:155-61.
7. el-Naggar AK, Batsakis JG, Luna MA, McLemore D, Byers RM. DNA flow cytometry of acinic cell carcinomas of major salivary glands. J Laryngol Otol 1990;104:410-6.
8. Nunes JF, Fonseca I, Soares J. Helioid inclusions in dedifferentiated acinic cell carcinoma of the parotid gland. Ultrastruct Pathol 1996;20:443-9.
9. Henley JD, Geary WA, Jackson CL, Wu CD, Gnepp DR. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity. Hum Pathol 1997;28:869-73.
10. Di Palma S, Corletto V, Lavarino C, Birindelli S, Pilotti S. Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland. Virchows Arch 1999;434:361-5.
11. Piana S, Cavazza A, Pedroni C, Scotti R, Serra L, Gardini G. Dedifferentiated acinic cell carcinoma of the parotid gland with myoepithelial features. Arch Pathol Lab Med 2002;126:1104-5.
12. Cheuk W, Chan JK, Ngan RK. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol 1999;23:465-72.
13. Moles MA, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:177-80.
14. Chau Y, Hongyo T, Aozasa K, Chan JK. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol 2001;32:1403-7.
15. Alos L, Carrillo R, Ramos J, Baez JM, Mallofre C, Fernandez PL, et al. High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands: clinicopathological, immunohistochemical and flow-cytometric study of three cases. Virchows Arch 1999;434:291-9.
16. Fonseca I, Felix A, Soares J. Dedifferentiation in salivary gland carcinomas. Am J Surg Pathol 2000;24:469-71.
17. Pelkey TJ, Mills SE. Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland. Am J Clin Pathol 1999;111:785-91.
18. Simpson RH, Pereira EM, Ribeiro AC, Abdulkadir A, Reis-Filho JS. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology 2002;41:250-9.
19. Nagao T, Sugano I, Ishida Y, Tajima Y, Munakata S, Asoh A, et al. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol 2000;13:554-61.
20. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-7.
21. Meis JM. "Dedifferentiation" in bone and soft-tissue tumors: a histological indicator of tumor progression. Pathol Annu 1991;26:37-62.
22. Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol 2002;15:298-323.
23. Cleveland D, Abrams AM, Melrose RJ, Handlers JP. Solid adenoid cystic carcinoma of the maxilla. Oral Surg Oral Med Oral Pathol 1990;69:470-8.
24. Nordgard S, Franzen G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997;107:531-6.
25. Seifert G, Donath K. Hybrid tumours of salivary glands: definition and classification of five rare cases. Eur J Cancer B Oral Oncol 1996;32B:251-9.
26. Nagao T, Sugano I, Ishida Y, Asoh A, Munakata S, Yamazaki K, et al. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis. Mod Pathol 2002;15:724-33.
27. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer 1996;77:223-30.
28. Kamio N, Tanaka Y, Mukai M, Ikeda E, Kuramochi S, Fujii M, et al. A hybrid carcinoma: adenoid cystic carcinoma and salivary duct carcinoma of the salivary gland: an immunohistochemical study. Virchows Arch 1997;430:495-500.
29. Snyder ML, Paulino AF. Hybrid carcinoma of the salivary gland: salivary duct adenocarcinoma adenoid cystic carcinoma. Histopathology 1999;35:380-3.
30. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 1995;75:2037-44.
31. Kamio N. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours. Virchows Arch 1996;428:75-83.
32. Yamamoto Y, Virmani AK, Wistuba II, McIntire D, Vuitch F, Albores-Saavedra J, et al. Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands. Hum Pathol 1996;27:1204-10.
33. Rosa JC, Felix A, Fonseca I, Soares J. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation. J Clin Pathol 1997; 50:661-3.
34. Grote HJ, Schneider-Stock R, Neumann W, Roessner A. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Virchows Arch 2000;436:494-7.